Dr. Shahram Majidi implants first device from Neuralink competitor Synchron

Carly Behm -  

Synchron, a medtech company developing a brain implant, completed its first patient case in a U.S. trial.

Shahram Majidi, MD, assistant professor of neurosurgery, neurology and radiology at the Icahn School of Medicine in New York City, performed the procedure, according to a July 19 news release. The device is implanted using an endovascular approach instead of an open-brain surgery.

Synchron began its trial in May. Its implant, Stentrode, is similar to Elon Musk's Neuralink and aims to help patients with spinal cord injuries. Neuralink is awaiting FDA approval while Stentrode has investigational device exemption from the agency.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers